Patent details

EP3533449 Title: SELECTIVE INHIBITOR OF EXON 20 INSERTION MUTANT EGFR

Basic Information

Publication number:
EP3533449
PCT Application Number:
JP2017037186
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178649752
PCT Publication Number:
WO2018079310
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SELECTIVE INHIBITOR OF EXON 20 INSERTION MUTANT EGFR
French Title of Invention:
INHIBITEUR SÉLECTIF DE L'EGFR MUTANT PAR INSERTION DE L'EXON 20
German Title of Invention:
SELEKTIVER HEMMER VON EXON-20-INSERTIONSMUTANTEM EGFR
SPC Number:

Dates

Filing date:
13/10/2017
Grant date:
12/07/2023
EP Publication Date:
04/09/2019
PCT Publication Date:
03/05/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/07/2023
EP B1 Publication Date:
12/07/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/10/2023
Expiration date:
13/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/07/2023
 
 

Name:
Taiho Pharmaceutical Co., Ltd.
Address:
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, Japan (JP)

Inventor

1

Name:
MIYADERA, Kazutaka
Address:
Japan (JP)

2

Name:
AOYAGI, Yoshimi
Address:
Japan (JP)

3

Name:
HASAKO, Shinichi
Address:
Japan (JP)

Priority

Priority Number:
2016213072
Priority Date:
31/10/2016
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/519; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202328
Publication date:
12/07/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages